Anti-AML Activity of Combined Epigenetic Therapy with Novel DNMT1 Inhibitors SGI-110 or SGI-1036 and Histone Deacetylase Inhibitor Panobinostat.

Autor: Fiskus, Warren *, Johnston, Pace *, Joshi, Rajeshree *, Rao, Rekha *, Ustun, Celalettin *, Jillella, Anand *, Atadja, Peter *, Hwang, Stuart *, Redkar, Sanjeev *, Bhalla, Kapil N.
Zdroj: In Blood 16 November 2008 112(11):3355-3355
Databáze: ScienceDirect